Midwest Immunology Clinic

Plymouth, Minnesota 55446

0 studies enrolling now · 5 studies all time

What they study most

Agammaglobulinemia, Antibody Deficiency, Hereditary Angioedema (HAE), Hypogammaglobulinemia, Primary Immune Deficiency, Primary Immunodeficiency

Studies at this site

• A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America — Completed
• Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE — Completed
• Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE — Completed
• Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) — Completed
• Retrospective Chart Review of Subcutaneous IgG Use in Infants — Completed